Literature DB >> 17377344

Dedicated decontamination: A necessity to prevent cross contamination in high throughput mycobacteriology laboratories.

C Rodrigues1, D Almeida, S Shenai, N Goyal, A Mehta.   

Abstract

UNLABELLED: Unrecognized cross-contamination has been known to occur in laboratories frequently, especially with sensitive recovery system like BACTEC 460 TB. In March 2001, we investigated a pseudo-outbreak of Mycobacterium tuberculosis isolates in three smear negative clinical specimens and would like to present our experience in this communication.
METHODS: All suspected cases were confirmed by checking the drug susceptibility and DNA fingerprints using spoligotyping as well as restriction fragment length polymorphism.
RESULTS: On investigation, the most likely cause was found to be the use of common decontamination reagents and phosphate buffer.
CONCLUSIONS: To avoid erroneous diagnosis, we have devised a dedicated decontamination procedure, which includes separate aliquoting of phosphate buffer and decontamination reagents per patient. Timely molecular analysis and appropriate changes to specimen processing have been identified as useful measures for limiting laboratory cross contamination.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17377344     DOI: 10.4103/0255-0857.31053

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  3 in total

1.  False-positive tuberculous meningitis due to laboratory contamination: importance of a holistic clinical evaluation.

Authors:  Saraschandra Vallabhajosyula; Renuga Vivekanandan; Edward A Horowitz
Journal:  BMJ Case Rep       Date:  2014-05-21

2.  Redefining MTBDRplus test results: what do indeterminate results actually mean?

Authors:  C Nikam; R Patel; M Sadani; K Ajbani; M Kazi; R Soman; A Shetty; S B Georghiou; T C Rodwell; A Catanzaro; C Rodrigues
Journal:  Int J Tuberc Lung Dis       Date:  2016-02       Impact factor: 2.373

3.  Evaluation of genotype MTBDRsl assay to detect drug resistance associated with fluoroquinolones, aminoglycosides and ethambutol on clinical sediments.

Authors:  Kanchan Ajbani; Chaitali Nikam; Mubin Kazi; Christen Gray; Catharina Boehme; Kavita Balan; Anjali Shetty; Camilla Rodrigues
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.